Mentinova

Drug for the treatment of L-Dopa Induced Dyskinesia in patients with Parkinson’s disease

placeNew Brunswick, New Jersey, United States calendar_todayFounded 2013 language mentinova.com

Innovation

1 patent family — focus: Human necessities; filing pace dormant. Cited 6 times.

YearFilings
20151

Investor mix

1 investor on record.

Investor typeCountShare
Venture capital1100%
Coming soon